Contact
Please use this form to send email to PR contact of this press release:
Atossa Genetics Receives Second Positive Safety Committee Decision in Phase 1 Topical Endoxifen Dose Escalation Study
TO:
Please use this form to send email to PR contact of this press release:
Atossa Genetics Receives Second Positive Safety Committee Decision in Phase 1 Topical Endoxifen Dose Escalation Study
TO: